4//SEC Filing
Byrnes Michael 4
Accession 0001209191-24-003680
CIK 0001828522other
Filed
Feb 20, 7:00 PM ET
Accepted
Feb 21, 5:02 PM ET
Size
5.8 KB
Accession
0001209191-24-003680
Insider Transaction Report
Form 4
Byrnes Michael
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-02-19+40,000→ 40,000 totalExercise: $11.32Exp: 2034-02-18→ Common Stock (40,000 underlying)
Footnotes (1)
- [F1]1/48th of the total number of shares subject to the options shall vest on each monthly anniversary of February 19, 2024 (the "Vesting Commencement Date"), subject to the Reporting Person's continuous service to the Issuer on each such vesting date, so that the options shall be fully vested on the fourth anniversary of the Vesting Commencement Date.
Documents
Issuer
eFFECTOR Therapeutics, Inc.
CIK 0001828522
Entity typeother
Related Parties
1- filerCIK 0001619893
Filing Metadata
- Form type
- 4
- Filed
- Feb 20, 7:00 PM ET
- Accepted
- Feb 21, 5:02 PM ET
- Size
- 5.8 KB